Cargando…
Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation
Vasopressin type-2 receptor (V2R) is ectopically expressed and plays a pathogenic role in clear cell renal cell carcinoma (ccRCC) tumor cells. Here we examined how V2R signaling within human ccRCC tumor cells (Caki1 cells) stimulates stromal cancer-associated fibroblasts (CAFs). We found that cell c...
Autores principales: | Jamadar, Abeda, Dwivedi, Nidhi, Mathew, Sijo, Calvet, James P., Thomas, Sufi M., Rao, Reena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325308/ https://www.ncbi.nlm.nih.gov/pubmed/35886951 http://dx.doi.org/10.3390/ijms23147601 |
Ejemplares similares
-
Targeting the Vasopressin Type 2 Receptor for Renal Cell Carcinoma Therapy
por: Sinha, Sonali, et al.
Publicado: (2019) -
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
por: Jamadar, Abeda, et al.
Publicado: (2021) -
Integrin β1 Promotes Pancreatic Tumor Growth by Upregulating Kindlin-2 and TGF-β Receptor-2
por: Mia, Md Saimon, et al.
Publicado: (2021) -
Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008) -
Oxytocin and Vasopressin Involved in Restraint Water-Immersion Stress Mediated by Oxytocin Receptor and Vasopressin 1b Receptor in Rat Brain
por: Zhao, Dong-Qin, et al.
Publicado: (2011)